Algert Global LLC Vir Biotechnology, Inc. Transaction History
Algert Global LLC
- $3.72 Billion
- Q3 2024
A detailed history of Algert Global LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Algert Global LLC holds 213,465 shares of VIR stock, worth $1.58 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
213,465
Previous 166,835
27.95%
Holding current value
$1.58 Million
Previous $1.49 Million
7.68%
% of portfolio
0.04%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding VIR
# of Institutions
218Shares Held
87MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$123 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$97.2 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$41.6 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$26.4 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $982M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...